Breaking News

Astellas to Open New Life Sciences Facility at Cambridge Crossing

Lab area will be occupied by a discovery accelerator, which will serve as an additional incubator space for external collaborators.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Astellas Pharma Inc. will open a new state-of-the-art life sciences facility in Cambridge, MA. The investment establishes a significant presence for Astellas in one of the world’s premier life science innovation hubs, showcasing the company’s commitment to expanding its R&D footprint to accelerate innovation. The facility will be the fifth lab-ready building at Cambridge Crossing. Astellas expects to occupy two floors, or approximately 62,000 square feet, of the new facility i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters